CNTN
Canton Strategic Holdings, Inc.
NASDAQ: CNTN · HEALTHCARE · BIOTECHNOLOGY
$3.23
+3.53% today
Updated 2026-04-30
Market cap
$186.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.12
Dividend yield
—
52W range
$1 – $9
Volume
0.6M
WallStSmart proprietary scores
27
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-10.44M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-8.47M | $-9.32M | $-12.20M | $-35.92M | $-29.42M |
| EPS | — | — | — | — | $-1.12 |
| Free cash flow | $-6.56M | $-7.30M | $-10.90M | $-93.70M | $-10.44M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Canton Strategic Holdings, Inc. trades at $3.23. Our Smart Value Score of 27/100 indicates the stock is weak.
Frequently asked questions
What is Canton Strategic Holdings, Inc.'s stock price?
Canton Strategic Holdings, Inc. (CNTN) trades at $3.23.
Is Canton Strategic Holdings, Inc. overvalued?
Smart Value Score 27/100 (Grade F, Strong Sell).
What is the price target of Canton Strategic Holdings, Inc. (CNTN)?
The analyst target price is $—, representing NaN% downside from the current price of $3.23.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-18.00%
Beta1.60
50D MA$3.87
200D MA$3.19
Shares out0.06B
Float0.05B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—